315.14

1.83% -5.28

Ligand Pharmaceuticals Inc (LGND)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$320.42

Aprire:

$317.97

Volume 24 ore:

219.17K

Relative Volume:

0.69

Capitalizzazione di mercato:

$6.31B

Reddito:

$274.48M

Utile/perdita netta:

$153.56M

Rapporto P/E:

42.73

EPS:

7.3755

Flusso di cassa netto:

$114.06M

1 W Prestazione:

-0.49%

1M Prestazione:

+32.72%

6M Prestazione:

+57.30%

1 anno Prestazione:

+176.50%

Intervallo 1D:

$312.74

$323.30

Intervallo di 1 settimana:

$305.31

$323.30

Portata 52W:

$114.00

$323.30

Ligand Pharmaceuticals Inc Stock (LGND) Company Profile

Nome

Ligand Pharmaceuticals Inc

Settore

Healthcare (1100)

Industria

Biotechnology (615)

Telefono

858-550-7500

Indirizzo

3911 SORRENTO VALLEY BLVD, SAN DIEGO, CA

Dipendente

Cinguettio

@Ligand_LGND

Prossima data di guadagno

2026-08-06

Ultimi documenti SEC

LGND's Discussions on Twitter

Compare LGND vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
LGND Ligand Pharmaceuticals Inc	314.92	6.42B	274.48M	153.56M	114.06M	7.3755
VRTX Vertex Pharmaceuticals Inc	522.00	134.41B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	672.79	68.13B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.13	57.01B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	319.99	41.79B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	190.13	40.39B	742.00K	-1.37B	-1.07B	-7.0731

Ligand Pharmaceuticals Inc Stock (LGND) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-03-11	Iniziato	BofA Securities	Buy
2025-12-09	Iniziato	Citigroup	Buy
2025-04-10	Iniziato	Stifel	Buy
2024-10-03	Iniziato	Oppenheimer	Outperform
2024-07-30	Iniziato	RBC Capital Mkts	Outperform
2021-04-14	Ripresa	Stephens	Overweight
2021-02-04	Reiterato	H.C. Wainwright	Buy
2020-10-06	Iniziato	Barclays	Overweight
2020-03-24	Downgrade	Argus	Buy → Hold
2020-03-10	Iniziato	Guggenheim	Neutral
2020-02-06	Iniziato	The Benchmark Company	Buy
2019-09-19	Aggiornamento	Barclays	Equal Weight → Overweight
2019-06-11	Iniziato	Barclays	Equal Weight
2019-05-03	Reiterato	H.C. Wainwright	Buy
2019-03-06	Reiterato	H.C. Wainwright	Buy
2018-10-29	Aggiornamento	ROTH Capital	Neutral → Buy
2018-10-02	Reiterato	H.C. Wainwright	Buy
2018-09-11	Reiterato	Argus	Buy
2018-08-17	Iniziato	Goldman	Neutral
2018-08-08	Downgrade	ROTH Capital	Buy → Neutral
2018-06-21	Iniziato	Argus	Buy
2017-12-27	Reiterato	H.C. Wainwright	Buy
2017-09-05	Ripresa	H.C. Wainwright	Buy
2016-10-05	Reiterato	H.C. Wainwright	Buy
2016-08-05	Downgrade	Deutsche Bank	Hold → Sell
2016-03-11	Iniziato	Sidoti	Buy
2016-03-03	Iniziato	H.C. Wainwright	Buy

Mostra tutto

Ligand Pharmaceuticals Inc Borsa (LGND) Ultime notizie

Jul 06, 2026

Form 4 Ligand Pharmaceuticals Incorporated For: 6 July By Investing.com - Investing.com Canada

Jul 06, 2026

Ligand Pharmaceuticals CLO Andrew Reardon sells $1.56m in shares By Investing.com - Investing.com Canada

Jul 06, 2026

[Form 4] LIGAND PHARMACEUTICALS INC Insider Trading Activity - Stock Titan

Jul 06, 2026

Ligand Pharmaceuticals (LGND) CFO adds 17 shares through stock purchase plan - Stock Titan

Jul 06, 2026

LGND CEO Todd Davis acquires stock through employee plan in Form 4 filing - Stock Titan

Jul 06, 2026

Ligand Pharmaceuticals stock hits all-time high at 321.33 USD - Investing.com

Jul 06, 2026

CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool

Jul 06, 2026

Jul 03, 2026

Ligand Pharmaceuticals explores licensing-driven growth as investors assess its royalty model - AD HOC NEWS

Jul 03, 2026

Ligand Pharmaceuticals Is Buying Xoma for Nearly $740 Million -- WSJ - Moomoo

Jul 03, 2026

Jul 02, 2026

Enterprise value to EBITDA forward of Ligand Pharmaceuticals Incorporated – OTC:LGNXZ - TradingView

Jul 02, 2026

TVTX, LGND Stocks In Spotlight Ahead Of Monday’s FDA Call On Kidney Drug Filspari - Stocktwits

Jul 02, 2026

Jul 01, 2026

LGND: 10,000-share Section 144 notice; prior 10b5-1 sales by Reardon (LGND) - Stock Titan

Jul 01, 2026

Enterprise value to revenue forward of Ligand Pharmaceuticals Incorporated – OTC:LGNXZ - TradingView

Jul 01, 2026

Jun 30, 2026

Ligand Pharma: Expect Bright And Exciting Future For This Growing Royalty Aggregator - Seeking Alpha

Jun 30, 2026

Price to sales forward of Ligand Pharmaceuticals Incorporated – OTC:LGNXZ - TradingView

Jun 30, 2026

Ligand Pharmaceuticals reaches new 52-week high as insiders trim holdings - AD HOC NEWS

Jun 30, 2026

Zerion Pharma completes royalty financing and equity investment transaction with Ligand to advance the Dispersome® technology - marketscreener.com

Jun 30, 2026

Enterprise value to revenue forward of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ - TradingView

Jun 30, 2026

Jun 29, 2026

Enterprise value to EBITDA forward of Ligand Pharmaceuticals Incorporated – NASDAQ:LGND - TradingView

Jun 29, 2026

Price to sales forward of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ - TradingView

Jun 29, 2026

Enterprise value to EBITDA forward of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ - TradingView

Jun 29, 2026

Enterprise value to EBIT forward of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ - TradingView

Jun 29, 2026

Price to book forward of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ - TradingView

Jun 29, 2026

Price to earnings forward of Ligand Pharmaceuticals Incorporated – OTC:LGNDZ - TradingView

Jun 29, 2026

Enterprise value to EBIT forward of Ligand Pharmaceuticals Incorporated – NASDAQ:LGND - TradingView

Jun 29, 2026

Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) dropped from Russell 2000 Value-Defensive Index - marketscreener.com

Jun 29, 2026

Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) dropped from Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Enterprise value to EBIT forward of Ligand Pharmaceuticals Incorporated – BX:LGDN - TradingView

Jun 29, 2026

Enterprise value to revenue forward of Ligand Pharmaceuticals Incorporated – NASDAQ:LGND - TradingView

Jun 29, 2026

Jun 28, 2026

Price to earnings forward of Ligand Pharmaceuticals Incorporated – NASDAQ:LGND - TradingView

Jun 28, 2026

Price to earnings forward of Ligand Pharmaceuticals Incorporated – BX:LGDN - TradingView

Jun 28, 2026

Price to book forward of Ligand Pharmaceuticals Incorporated – BX:LGDN - TradingView

Jun 28, 2026

Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) dropped from Russell 3000 Value Benchmark - marketscreener.com

Jun 28, 2026

Price to sales forward of Ligand Pharmaceuticals Incorporated – BX:LGDN - TradingView

Jun 28, 2026

Ligand Pharmaceuticals Incorporated(NasdaqGM:LGND) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 27, 2026

XOMA Royalty (XOMA) Stock Fair Value Falls After Ligand Agrees Cash Acquisition - Yahoo Finance

Jun 27, 2026

Ligand Pharmaceuticals Incorporated Actuals & Estimates (NASDAQ:LGND) - TradingView

Jun 27, 2026

Jun 26, 2026

Ligand completes $700m convertible notes offering By Investing.com - Investing.com Australia

Jun 26, 2026

LGND Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026